In Situ Tumor Vaccination with Calcium‐Linked Degradable Coacervate Nanocomplex Co‐Delivering Photosensitizer and TLR7/8 Agonist to Trigger Effective Anti‐Tumor Immune Responses
Authors:
- 24 March 2022
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 11 (12) , e2102781
Abstract
In situ anti‐tumor vaccination is an attractive type of cancer immunotherapy which relies on the effectiveness of dendritic cells (DCs) to engulf tumor antigens, become activated, and present antigens to T cells in lymphoid tissue. Here, a multifunctional nanocomplex based on calcium crosslinked polyaspartic acid conjugated to either a toll‐like receptor (TLR)7/8 agonist or a photosensitizer is reported. Intratumoral administration of the nanocomplex followed by laser irradiation induces cell killing and hence generation of a pool of tumor‐associated antigens, with concomitant promotion of DCs maturation and expansion of T cells in tumor‐draining lymph nodes. Suppression of tumor growth is observed both at the primary site and at the distal site, thereby hinting at successful induction of an adaptive anti‐tumor response. This strategy holds promise for therapeutic application in a pre‐operative and post‐operative setting to leverage to mutanome of the patient's own tumor to mount immunological memory to clear residual tumor cells and metastasis.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2021QH024, ZR2020QH350)
- National Natural Science Foundation of China (82003680)
This publication has 31 references indexed in Scilit:
- Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBMScience Translational Medicine, 2016
- Immunogenic cell death in cancer and infectious diseaseNature Reviews Immunology, 2016
- Vaccines for established cancer: overcoming the challenges posed by immune evasionNature Reviews Cancer, 2016
- Understanding Local Macrophage Phenotypes In Disease: Modulating macrophage function to treat cancerNature Medicine, 2015
- Assembly and localization of Toll-like receptor signalling complexesNature Reviews Immunology, 2014
- Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agentBiomaterials, 2014
- The role of dendritic cells in autoimmunityNature Reviews Immunology, 2013
- A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imagingBiomaterials, 2010
- Ex Vivo Stimulation of Tumor-Draining Lymph Node Cells from Lung Cancer Patients: A Potential Resource for Adoptive ImmunotherapyCellular & Molecular Immunology, 2008
- Dendritic cells as therapeutic vaccines against cancerNature Reviews Immunology, 2005